Technical Analysis for IFRX - InflaRx N.V.

Grade Last Price % Change Price Change
grade F 2.33 0.43% 0.01
IFRX closed up 0.43 percent on Monday, November 18, 2019, on 68 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical IFRX trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Calm After Storm Range Contraction 0.43%
Down 3 Days in a Row Weakness 0.43%
Down 4 Days in a Row Weakness 0.43%
Down 5 Days in a Row Weakness 0.43%
Oversold Stochastic Weakness 0.43%
MACD Bearish Centerline Cross Bearish -0.85%
Calm After Storm Range Contraction -0.85%

Older signals for IFRX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Inflarx NV, formerly Fireman BV, is a holding company for InflaRx GmbH, a Germany-based clinical-stage biopharmaceutical company. The Company's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in the treatment of life-threatening inflammatory diseases. Its lead product candidate, IFX-1, is an intravenously delivered first-in-class anti-C5a monoclonal antibody, undergoing Phase II clinical trial for the treatment of Hidradenitis Suppurativa (HS), a rare and chronic debilitating systemic inflammatory skin disease, and entering Phase II clinical trial for the treatment of ANCA-associated vasculitis (AAV) and other rare autoimmune diseases. The Company's product pipeline also includes IFX-2, which is in preclinical development.
Medicine Biotechnology Biopharmaceutical Medical Specialties Immunology Antibodies Immune System Monoclonal Antibodies Inflammatory Diseases
Is IFRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 53.1
52 Week Low 2.17
Average Volume 409,430
200-Day Moving Average 18.7238
50-Day Moving Average 2.5704
20-Day Moving Average 2.543
10-Day Moving Average 2.535
Average True Range 0.1902
ADX 20.68
+DI 18.7996
-DI 20.8103
Chandelier Exit (Long, 3 ATRs ) 2.5294
Chandelier Exit (Short, 3 ATRs ) 2.7506
Upper Bollinger Band 2.8903
Lower Bollinger Band 2.1957
Percent B (%b) 0.19
BandWidth 27.314196
MACD Line -0.0357
MACD Signal Line -0.0011
MACD Histogram -0.0347
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.48
Resistance 3 (R3) 2.48 2.43 2.46
Resistance 2 (R2) 2.43 2.39 2.43 2.45
Resistance 1 (R1) 2.38 2.37 2.38 2.38 2.44
Pivot Point 2.33 2.33 2.33 2.33 2.33
Support 1 (S1) 2.28 2.29 2.28 2.28 2.22
Support 2 (S2) 2.23 2.27 2.23 2.21
Support 3 (S3) 2.18 2.23 2.21
Support 4 (S4) 2.18